Aaron VanDevender - 28 Feb 2022 Form 4 Insider Report for Applied Molecular Transport Inc.

Role
Director
Signature
/s/ Brandon Hants Attorney-in-Fact for Aaron vanDevender
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
+$317,699
Form type
4
Filing time
02 Mar 2022, 16:15:20 UTC
Previous filing
20 May 2021
Next filing
26 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMTI Common Stock Purchase $26,769 +4,112 +32% $6.51* 16,771 28 Feb 2022 Direct F1
transaction AMTI Common Stock Purchase $290,930 +45,888 +274% $6.34* 62,659 01 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.46 to $6.55, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in column is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.60, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.